Keyphrases
Maastricht
100%
Pre-diabetes (pre-DM)
100%
Glycemia
100%
Glucose Variability
100%
Retinal Nerve Fiber Layer Thickness (RNFLT)
100%
Glucose Metabolism Status
66%
Glycaemia
66%
Type 2 Diabetes Mellitus (T2DM)
50%
Retinopathy
33%
Neuropathy
33%
Fasting Plasma Glucose
33%
Hemoglobin A1c (HbA1c)
33%
Neurodegeneration
33%
Continuous Glucose Monitoring
33%
Skin Autofluorescence
33%
Glucose Tolerance
33%
Post-load Glucose
33%
Retinal Nerve Fiber Layer Thinning
33%
Population-based Study
16%
Cardiovascular Risk
16%
Lifestyle Factors
16%
Hyperglycemia
16%
Linear Regression Analysis
16%
Advanced Glycation End Products
16%
Treatment Monitoring
16%
Normal Glucose Tolerance
16%
Early Identification
16%
Individual Identification
16%
Trend Analysis
16%
Glucose-lowering Drugs
16%
Studying up
16%
Early Monitoring
16%
Type 2 Prediabetes
16%
Skin Index
16%
P for Trend
16%
INIS
glucose
100%
fibers
100%
nerves
100%
layers
100%
thickness
100%
metabolism
22%
monitoring
13%
skin
9%
peaks
9%
range
9%
tolerance
9%
plasma
9%
fasting
9%
data
4%
risks
4%
regression analysis
4%
populations
4%
precursor
4%
adjustments
4%
men
4%
hyperglycemia
4%
Medicine and Dentistry
Impaired Glucose Tolerance
100%
Retinal Nerve Fiber Layer
100%
Glucose Metabolism
62%
Maturity Onset Diabetes of the Young
37%
Glucose Tolerance
25%
Autofluorescence
25%
Retinopathy
25%
Hemoglobin A1c
25%
Neuropathy
25%
Glucose Test
25%
Neurodegeneration
25%
Precursor
12%
Linear Regression Analysis
12%
Cardiovascular Risk
12%
Hyperglycemia
12%
Advanced Glycation End-Product
12%
Neuroscience
Nerve Fiber
100%
Metabolic Pathway
62%
Neurodegeneration
25%
Glucose Tolerance Test
25%
Autofluorescence
25%
Hemoglobin A1c
25%
Retinal Disease
25%
Peripheral Neuropathy
25%
Advanced Glycation End Product
12%
Hyperglycemia
12%